LAVIPHARM S.A. NA EO 1 Free Cash Flow Generation Index
LAVIPHARM S.A. NA EO 1 free cash flow generation index. LAVIPHARM S.A. NA EO 1 (BXA0) has a Free Cash Flow Generation Index of -1.08x as of December 2024. Free cash flow of €-5.00 Million represents -1% of operating cash flow (€4.64 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of LAVIPHARM S.A. NA EO 1 (2021–2024)
Free cash flow generation index of LAVIPHARM S.A. NA EO 1 from 2021 to 2024. Historical FCF Generation Index trend for LAVIPHARM S.A. NA EO 1 across 4 annual periods. See BXA0 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
LAVIPHARM S.A. NA EO 1 Free Cash Flow Generation Index by Year (2021–2024)
LAVIPHARM S.A. NA EO 1 free cash flow generation index by year from 2021 to 2024. Year-by-year Free Cash Flow Generation Index for LAVIPHARM S.A. NA EO 1. For the full cash flow conversion analysis, see LAVIPHARM S.A. NA EO 1 (BXA0) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.08x | €-5.00 Million | €4.64 Million | €9.64 Million | ▲ +91.9% |
| 2023 | -13.26x | €-3.77 Million | €284.00K | €4.05 Million | ▼ -37.5% |
| 2022 | -9.64x | €-32.27 Million | €3.35 Million | €35.62 Million | ▼ -1907.9% |
| 2021 | 0.53x | €2.19 Million | €4.11 Million | €1.92 Million | — |